- Udyam number
- UDYAM-TS-20-0031296

About Express Pharmaceuticals Private Limited
Data last updated:
Express Pharmaceuticals Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 17 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC137678. Its GSTIN is 36AAFCE7510F1ZV (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Nurali Barkatali Baghdiya and Aadil Anvarbhai Virani.
Its last annual general meeting (AGM) was held on 09 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #208 Varuna Towers Sri Vensai Projects Kompally, Secunderabad, Telangana, India – 500014.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.91 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹17.06 Lakh (net margin 1.3%) and EBITDA of ₹16.1 Lakh (EBITDA margin 1.2%).
The company is associated with 1 brand: Express Pharmaceuticals.
Express Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-20-0031296). For more details, the company can be reached via its website expresspharmaceuticals.com.
Company details
Recognitions & Rankings of Express Pharmaceuticals
Contact details
Express Pharmaceuticals Private Limited's registered office is in Secunderabad, Telangana. Its website is expresspharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address#208 Varuna Towers Sri Vensai Projects Kompally, Secunderabad, Telangana, India – 500014
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Express Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Express Pharmaceuticals operates one associated brand: Express Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and exporting in India. | expresspharmaceuticals.com |
Business activity
The main business activity of Express Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Express Pharmaceuticals Private Limited, buy the company report.
Financials of Express Pharmaceuticals Private Limited
FY 2025 filings availableExpress Pharmaceuticals Private Limited reported revenue of ₹12.91 Cr (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Express Pharmaceuticals Private Limited, buy the company report.
Board of directors of Express Pharmaceuticals Private Limited
Express Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nurali Barkatali Baghdiya | Director | 17 Dec 2019 | 6 Years 11 Months | Current |
| Aadil Anvarbhai Virani | Director | 17 Dec 2019 | 6 Years 11 Months | Current |
| Dilavar Alibhai Abhavani Also directs: Avenza Pharmaceuticals Private Limited | Director | 17 Dec 2019 | 6 Years 11 Months | Current |
Auditor
Express Pharmaceuticals Private Limited is audited by RAMESH & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMESH & ASSOCIATES | FY 2021 | 012398S |
Shareholding
The shareholding of Express Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Express Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Express Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Express Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Express Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCE7510F1ZV | Telangana | Active | 21 Feb 2020 |
To see the full GST registrations and return filing status of Express Pharmaceuticals Private Limited, buy the company report.
Recent activity
Express Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Aadil Anvarbhai Virani was appointed as Director on 17 Dec 2019.
Frequently asked questions
Express Pharmaceuticals is an active private limited company based in Secunderabad, Telangana, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 17 December 2019 (7+ years old) and is registered under CIN U51909TG2019PTC137678.
Express Pharmaceuticals has 3 current directors:
- Nurali Barkatali Baghdiya - Director
- Aadil Anvarbhai Virani - Director
- Dilavar Alibhai Abhavani - Director
The latest financial statements of Express Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 09 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Express Pharmaceuticals is 36AAFCE7510F1ZV, registered in Telangana.
The CIN (Corporate Identification Number) of Express Pharmaceuticals is U51909TG2019PTC137678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Express Pharmaceuticals was incorporated on 17 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aadil Anvarbhai Virani was appointed as Director on 17 Dec 2019. Dilavar Alibhai Abhavani was appointed as Director on 17 Dec 2019. Nurali Barkatali Baghdiya was appointed as Director on 17 Dec 2019.
Yes, Express Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-TS-20-0031296).
Express Pharmaceuticals can be reached through the website expresspharmaceuticals.com. Its registered office is in Secunderabad, Telangana, India.
The registered office of Express Pharmaceuticals is at #208 Varuna Towers Sri Vensai Projects Kompally, Secunderabad, Telangana, India – 500014.

